Amesite INC 8-K filings

Amesite Inc. has entered into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC, allowing for the sale of its common stock up to a specified aggregate offering price.

Amesite Inc. announced that its stockholders approved an amendment to the 2018 Equity Incentive Plan, increasing available shares by 1,000,000.

Amesite Inc. announced a significant new enterprise customer for its NurseMagic platform, representing its largest deployment to date and validating its AI-native infrastructure strategy.

Amesite Inc. announced the pricing of concurrent registered direct and private offerings, raising approximately $2.6 million in gross proceeds, with additional potential proceeds from warrant exercises.

Amesite Inc. announced a 69% quarter-over-quarter revenue increase in Q2 2026, alongside reduced spending and plans to launch an AI-powered Electronic Medical Record platform by 2026.

Amesite Inc. received a Nasdaq deficiency letter for failing to meet minimum stockholders' equity and other listing standards, initiating a 45-day period to submit a compliance plan.

Amesite Inc. has dismissed its independent auditor, Turner, Stone & Company, L.L.P., and appointed Novogradac & Company LLP, following disclosures of material weaknesses in its internal financial reporting controls and a prior going concern warning.

Amesite Inc. reports a significant 2.4x revenue increase in Q3 2025, fueled by its NurseMagicTM app and strategic sales and marketing efforts.

Amesite Inc. unveils a new corporate introductory video showcasing the company and its recently launched mobile healthcare app, NurseMagic.

Amesite Inc. showcases rapid adoption of its NurseMagic app, achieving significant revenue and market penetration in both B2C and B2B sectors.

Amesite Inc. held its annual meeting on January 21, 2025, where stockholders elected directors and ratified the appointment of its independent auditor.

Amesite Inc. successfully closes a $3.6 million public offering to fund corporate purposes, capital expenditures, and working capital.

Amesite Inc. showcases the rapid adoption and revenue growth of its NurseMagic AI-powered platform, targeting both B2C and B2B healthcare markets.

Amesite Inc. reports the immediate resignation of two board members, Anthony Barkett and Richard Ogawa, effective December 23, 2024, for personal reasons.

Amesite Inc. received a notice from Nasdaq for failing to meet the minimum stockholders' equity requirement for continued listing.

Amesite Inc. has appointed Sarah Berman as its new Principal Financial and Accounting Officer, effective December 15, 2024, replacing Sherlyn W. Farrell.

Amesite Inc. highlights rapid adoption of its NurseMagic app and growth in its higher education platform, alongside significant cost reductions and a strong financial position.

Amesite Inc. released presentation materials as part of a shareholder update on July 25, 2024, detailing the company's operations and performance.

Amesite Inc. has announced the beta launch of PREACTO, an AI-powered app designed for personal safety and security, in collaboration with active shooter expert Chris Grollnek.

Amesite Inc. stockholders approved an amendment to the 2018 Equity Incentive Plan, increasing the number of shares available for issuance by 508,488.

Amesite Inc. has amended its bylaws to reduce the quorum requirement for stockholder meetings to 33 1/3% of outstanding voting shares.

Amesite Inc. outlined its AI-powered online learning systems for higher education and professionals, emphasizing a no-risk, no-setup-fee model and new B2C applications.

Amesite is focusing on AI-powered online learning systems for colleges and universities, offering a no-risk, no setup fee model to scale professional development programs.

Amesite Inc. has issued 250,000 restricted common shares to Laidlaw & Company (UK) Ltd. as part of an advisory agreement.

Amesite Inc. held its annual stockholder meeting on January 18, 2024, where stockholders elected three Class III directors and ratified the appointment of Turner, Stone & Company, L.L.P. as the company's independent auditor.